| Primary |
| Somnolence |
12.6% |
| Fungal Infection |
11.7% |
| Product Used For Unknown Indication |
10.7% |
| Schizophrenia |
9.7% |
| B-cell Lymphoma |
6.8% |
| Candidiasis |
4.9% |
| Dyspnoea |
3.9% |
| Major Depression |
3.9% |
| Sepsis |
3.9% |
| Acute Lymphocytic Leukaemia |
2.9% |
| Antifungal Treatment |
2.9% |
| Atrial Fibrillation |
2.9% |
| Bipolar Disorder |
2.9% |
| Cardiac Failure |
2.9% |
| Diffuse Large B-cell Lymphoma |
2.9% |
| Dry Mouth |
2.9% |
| Glossodynia |
2.9% |
| Immunosuppressant Drug Therapy |
2.9% |
| Insomnia |
2.9% |
| Mania |
2.9% |
|
| Myocardial Infarction |
10.0% |
| Bone Marrow Failure |
7.5% |
| Folliculitis |
7.5% |
| Rash Papular |
7.5% |
| Urticaria |
7.5% |
| Aspergillosis |
5.0% |
| Death |
5.0% |
| Drug Effect Decreased |
5.0% |
| Drug Hypersensitivity |
5.0% |
| Hepatic Enzyme Increased |
5.0% |
| Ileus Paralytic |
5.0% |
| Rash Morbilliform |
5.0% |
| Rash Pruritic |
5.0% |
| Schizophrenia |
5.0% |
| Abasia |
2.5% |
| Abdominal Pain Upper |
2.5% |
| Activities Of Daily Living Impaired |
2.5% |
| Anaphylactic Reaction |
2.5% |
| Asthenia |
2.5% |
| Blood Alcohol Increased |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
51.1% |
| Rheumatoid Arthritis |
9.5% |
| Cataplexy |
5.4% |
| Osteoporosis |
4.7% |
| Narcolepsy |
4.1% |
| Gastritis |
3.8% |
| Dizziness |
1.9% |
| Dry Mouth |
1.9% |
| Dyspnoea |
1.9% |
| Gastrointestinal Disorder Therapy |
1.9% |
| Glossodynia |
1.9% |
| Pain Management |
1.9% |
| Pneumonia |
1.9% |
| Prophylaxis |
1.9% |
| Somnolence |
1.9% |
| Delusion |
1.3% |
| Hypertonic Bladder |
0.9% |
| Pain |
0.9% |
| Candidiasis |
0.6% |
| Depression |
0.6% |
|
| Completed Suicide |
25.9% |
| Toxicity To Various Agents |
13.0% |
| Pneumonia Cryptococcal |
7.4% |
| Vomiting |
5.6% |
| Weight Increased |
5.6% |
| Wound |
5.6% |
| Anxiety |
3.7% |
| Drug Dose Omission |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Suicidal Ideation |
3.7% |
| Weight Decreased |
3.7% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Arthralgia |
1.9% |
| Atrial Fibrillation |
1.9% |
| Blood Cholesterol Abnormal |
1.9% |
| Breast Cancer Metastatic |
1.9% |
| Cellulitis |
1.9% |
| Choking Sensation |
1.9% |
| Cough |
1.9% |
| Death |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.9% |
| Prophylaxis |
8.4% |
| Pain |
7.9% |
| Cataplexy |
6.0% |
| Narcolepsy |
5.7% |
| Depression |
4.5% |
| Adult T-cell Lymphoma/leukaemia |
3.4% |
| Diabetes Mellitus |
3.2% |
| Multiple Myeloma |
3.1% |
| Anxiety |
2.8% |
| Somnolence |
2.8% |
| Nausea |
2.7% |
| Hypertension |
2.5% |
| Sleep Disorder |
2.5% |
| Breast Cancer |
2.4% |
| Vitamin Supplementation |
2.4% |
| Arthritis |
2.3% |
| Multiple Sclerosis |
2.3% |
| Fungal Infection |
2.2% |
| Rheumatoid Arthritis |
2.2% |
|
| Weight Decreased |
18.3% |
| Pneumonia |
9.2% |
| Vomiting |
7.8% |
| Weight Increased |
5.9% |
| Anxiety |
5.2% |
| Pain In Extremity |
5.2% |
| Pulmonary Embolism |
4.6% |
| Somnolence |
4.6% |
| Tremor |
4.6% |
| Depression |
3.9% |
| Diarrhoea |
3.9% |
| Nausea |
3.9% |
| Headache |
3.3% |
| Pain |
3.3% |
| Rash |
3.3% |
| Aids Encephalopathy |
2.6% |
| Cholelithiasis |
2.6% |
| Dizziness |
2.6% |
| Drug Ineffective |
2.6% |
| Feeling Abnormal |
2.6% |
|
| Interacting |
| Lyme Disease |
20.6% |
| Atrial Fibrillation |
17.6% |
| Product Used For Unknown Indication |
17.6% |
| Prostate Cancer Metastatic |
17.6% |
| Convulsion Prophylaxis |
5.9% |
| Depression |
5.9% |
| Fungal Infection |
5.9% |
| Asthenia |
2.9% |
| Sleep Apnoea Syndrome |
2.9% |
| Vitamin Supplementation |
2.9% |
|
| International Normalised Ratio Increased |
60.0% |
| Drug Interaction |
10.0% |
| Pancreatitis |
10.0% |
| Psychiatric Symptom |
10.0% |
| Somnolence |
10.0% |
|
